1
|
Ikeda K, Torigoe T, Matsumoto Y, Fujita T,
Sato N and Yotsuyanagi T: Resveratrol inhibits fibrogenesis and
induces apoptosis in keloid fibroblasts. Wound Repair Regen.
21:616–623. 2013.PubMed/NCBI View Article : Google Scholar
|
2
|
Hunasgi S, Koneru A, Vanishree M and
Shamala R: Keloid: A case report and review of pathophysiology and
differences between keloid and hypertrophic scars. J Oral
Maxillofac Pathol. 17:116–120. 2013.PubMed/NCBI View Article : Google Scholar
|
3
|
Bettinger DA, Yager DR, Diegelmann RF and
Cohen IK: The effect of TGF-beta on keloid fibroblast proliferation
and collagen synthesis. Plastic Reconst Surg. 98:827–833.
1996.PubMed/NCBI View Article : Google Scholar
|
4
|
Harty M, Neff AW, King MW and Mescher AL:
Regeneration or scarring: An immunologic perspective. Dev Dyn.
226:268–279. 2003.PubMed/NCBI View Article : Google Scholar
|
5
|
Dong XL, Mao SL and Wen H: Upregulation of
proinflammatory genes in skin lesions may be the cause of keloid
formation (Review). Biomed Rep. 1:833–836. 2013.PubMed/NCBI View Article : Google Scholar
|
6
|
Frances B: TNF-alpha in promotion and
progression of cancer. Cancer Metastasis Rev. 25:409–416.
2006.PubMed/NCBI View Article : Google Scholar
|
7
|
Bahcecioglu IH, Koca SS, Poyrazoglu OK,
Yalniz M, Ozercan IH, Ustundag B, Sahin K, Dagli AF and Isik A:
Hepatoprotective effect of infliximab, an anti-TNF-α agent, on
carbon tetrachloride-induced hepatic fibrosis. Inflammation.
31:215–221. 2008.PubMed/NCBI View Article : Google Scholar
|
8
|
McCauley RL, Chopra V, Li YY, Herndon DN
and Robson MC: Altered cytokine production in black patients with
keloids. J Clin Immunol. 12:300–308. 1992.PubMed/NCBI View Article : Google Scholar
|
9
|
Messadi DV, Doung HS, Zhang Q, Kelly AP,
Tuan TL, Reichenberger E and Le AD: Activation of NFkappaB signal
pathways in keloid fibroblasts. Arch Dermatol Res. 296:125–133.
2004.PubMed/NCBI View Article : Google Scholar
|
10
|
Zhu GY, Cai JL, Zhang J, Zhao YR and Xu B:
Abnormal nuclear factor (NF)-kappaB signal pathway and aspirin
inhibits tumor necrosis factor α-induced NF-kappaB activation in
keloid fibroblasts. Dermatol Surg. 33:697–708. 2007.PubMed/NCBI View Article : Google Scholar
|
11
|
Wajant H, Pfizenmaier K and Scheurich P:
Tumor necrosis factor signaling. Cell Death Differ. 10:45–65.
2003.PubMed/NCBI View Article : Google Scholar
|
12
|
Gauglitz GG, Korting HC, Pavicic T,
Ruzicka T and Jeschke MG: Hypertrophic scarring and keloids:
Pathomechanisms and current and emerging treatment strategies. Mol
Med. 17:113–125. 2011.PubMed/NCBI View Article : Google Scholar
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C (T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
14
|
Crambert G, Li C, Claeys D and Geering K:
FXYD3 (Mat-8), a new regulator of Na, K-ATPase. Mol Biol Cell.
16:2363–2371. 2005.PubMed/NCBI View Article : Google Scholar
|
15
|
Liu LP, Chen FC, Guo LL and Chen YT:
Expression and significance of apoptosis-related TNFR1 and Bcl-2 in
fibroblasts derived from pathologic scar. Chin J Prac Aesthetic and
Plastic Surg. 15:272–274. 2004.
|
16
|
Peruccio D, Castagnoli C, Stella M,
D'Alfonso S, Momigliano PR, Magliacani G and Alasia ST: Altered
biosynthesis of tumour necrosis factor (TNF) alpha is involved in
postburn hypertrophic scars. Burns. 20:118–121. 1994.PubMed/NCBI View Article : Google Scholar
|
17
|
Miyazaki Y, Araki K, Vesin C, Garcia I,
Kapanci Y, Whitsett JA, Piguet PF and Vassalli P: Expression of a
tumor necrosis factor-alpha transgene in murine lung causes
lymphocytic and fibrosing alveolitis. A mouse model of progressive
pulmonary fibrosis. J Clin Invest. 96:250–259. 1995.PubMed/NCBI View Article : Google Scholar
|
18
|
Guo G, Morrissey J, McCracken R, Tolley T
and Klahr S: Role of TNFR1 and TNFR2 receptors in
tubulointerstitial fibrosis of obstructive nephropathy. Am J
Physiol. 277:F766–F772. 1999.PubMed/NCBI View Article : Google Scholar
|
19
|
Gurevitch J, Frolkis I, Yuhas Y,
Lifschitz-Mercer B, Berger E, Paz Y, Matsa M, Kramer A and Mohr R:
Anti-tumor necrosis factor-alpha improves myocardial recovery after
ischemia and reperfusion. J Am Coll Cardiol. 30:1554–1561.
1997.PubMed/NCBI View Article : Google Scholar
|
20
|
Weiner FR, Giambrone MA, Czaja MJ, Shah A,
Annoni G, Takahashi S, Eghbali M and Zern MA: Ito-cell gene
expression and collagen regulation. Hepatology. 11:111–117.
1990.PubMed/NCBI View Article : Google Scholar
|
21
|
Elias JA, Freundlich B, Kern JA and
Rosenbloom J: Cytokine networks in the regulation of inflammation
and fibrosis in the lung. Chest. 97:1439–1445. 1990.PubMed/NCBI View Article : Google Scholar
|
22
|
Lamb JA, Ventura JJ, Hess P, Flavell RA
and Davis RJ: JunD mediates survival signaling by the JNK signal
transduction pathway. Mol Cell. 11:1479–1489. 2003.PubMed/NCBI View Article : Google Scholar
|
23
|
Ventura JJ, Hübner A, Zhang C, Flavell RA,
Shokat KM and Davis RJ: Chemical genetic analysis of the time
course of signal transduction by JNK. Mol Cell. 21:701–710.
2006.PubMed/NCBI View Article : Google Scholar
|